If you need more lookups,
subscriptions start at $34 USD/month.
Brian Mead Location
Brookline, MA, US
Brian Mead Work
2026 -now Director, Translational Research @
2024 -2026 Director, Head of Pharmacology @
2023 -2024 Associate Director, Pharmacology @
2022 -2023 Associate Director, Pharmacology and Bio-analytics @
2021 -2022 Group Lead, Pharmacology and Bio-analytics @
2020 -2021 Senior Scientist and Team Lead, Pharmacology @
2019 -2020 Scientist, Pharmacology @
2018 -2019 Scientist, Delivery Nanotechnologies @
2017 -2018 Postdoctoral Researcher @
2012 -2017 Ph.D. in Biomedical Engineering @
2009 -2011 Math and Science Teacher @
2006 -2009 Undergraduate Researcher @
2008 -2008 REU Undergraduate Scholar @
Brian Mead Education
University of Virginia
Doctor of Philosophy - PhD (Biomedical Engineering)
2012-2017
University of Pittsburgh
Bachelor of Science (Molecular Biology (Biochemistry Track))
2005-2009
Brian Mead Skills
Research
Data Analysis
Teaching
Medical Ultrasound
Confocal Microscopy
Public Health
Protein Chemistry
Grant Writing
Chemistry
Biomedical Engineering
Physics
Molecular Biology
Statistics
Polymerase Chain Reaction (PCR)
Cell Culture
Nanotechnology
Western Blotting
Microscopy
Fluorescence Microscopy
Biochemistry
Animal Behavior
Immunohistochemistry
Microsoft Office
SPSS
Microsoft Excel
Microsoft PowerPoint
MATLAB
Community Outreach
Leadership
Gene Delivery
Ultrasound Therapy
Immunofluorescence
Neuroscience
GraphPad Prism
ELISA
Cell Biology
Brian Mead Summary
Brian Mead, based in Brookline, MA, US, is currently a Director, Translational Research at CREATE Medicines. Brian Mead brings experience from previous roles at Flagship Pioneering and GenEdit. Brian Mead holds a 2012 - 2017 Doctor of Philosophy - PhD in Biomedical Engineering @ University of Virginia. With a robust skill set that includes Research, Data Analysis, Teaching, Medical Ultrasound, Confocal Microscopy and more. Brian Mead has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Brian Mead?
Find contact details for 700 million professionals.